Sections
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 5 |
| 1.1 List of Tables | 5 | 1 |
| 1.2 List of Figures | 6 | 1 |
| 2 Introduction | 7 | 1 |
| 2.1 Spinal Cord Stimulators Overview | 7 | 1 |
| 3 Products under Development | 8 | 5 |
| 3.1 Spinal Cord Stimulators - Pipeline Products by Stage of Development | 8 | 1 |
| 3.2 Spinal Cord Stimulators - Pipeline Products by Territory | 9 | 1 |
| 3.3 Spinal Cord Stimulators - Pipeline Products by Regulatory Path | 10 | 1 |
| 3.4 Spinal Cord Stimulators - Pipeline Products by Estimated Approval Date | 11 | 1 |
| 3.5 Spinal Cord Stimulators - Ongoing Clinical Trials | 12 | 1 |
| 4 Spinal Cord Stimulators - Pipeline Products under Development by Companies | 13 | 2 |
| 4.1 Spinal Cord Stimulators Companies - Pipeline Products by Stage of Development | 13 | 1 |
| 4.2 Spinal Cord Stimulators - Pipeline Products by Stage of Development | 14 | 1 |
| 5 Spinal Cord Stimulators Companies and Product Overview | 15 | 28 |
| 5.1 Direct Spinal Therapeutics, Inc. Company Overview | 15 | 1 |
| 5.1.1 Direct Spinal Therapeutics, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 15 | 1 |
| 5.2 Duke University Company Overview | 16 | 1 |
| 5.2.1 Duke University Pipeline Products &Ongoing Clinical Trials Overview | 16 | 1 |
| 5.3 G-Therapeutics SA Company Overview | 17 | 1 |
| 5.3.1 G-Therapeutics SA Pipeline Products &Ongoing Clinical Trials Overview | 17 | 1 |
| 5.4 Imperial College London Company Overview | 18 | 1 |
| 5.4.1 Imperial College London Pipeline Products &Ongoing Clinical Trials Overview | 18 | 1 |
| 5.5 Meagan Medical Inc. Company Overview | 19 | 1 |
| 5.5.1 Meagan Medical Inc. Pipeline Products &Ongoing Clinical Trials Overview | 19 | 1 |
| 5.6 Medtrode Inc. Company Overview | 20 | 1 |
| 5.6.1 Medtrode Inc. Pipeline Products &Ongoing Clinical Trials Overview | 20 | 2 |
| 5.7 Medtronic plc Company Overview | 22 | 1 |
| 5.7.1 Medtronic plc Pipeline Products &Ongoing Clinical Trials Overview | 22 | 4 |
| 5.8 MicroTransponder Inc. Company Overview | 26 | 1 |
| 5.8.1 MicroTransponder Inc. Pipeline Products &Ongoing Clinical Trials Overview | 26 | 2 |
| 5.9 NeuroRecovery Technologies Inc. Company Overview | 28 | 1 |
| 5.9.1 NeuroRecovery Technologies Inc. Pipeline Products &Ongoing Clinical Trials Overview | 28 | 2 |
| 5.10 PathMaker Neurosystems Inc Company Overview | 30 | 1 |
| 5.10.1 PathMaker Neurosystems Inc Pipeline Products &Ongoing Clinical Trials Overview | 30 | 3 |
| 5.11 Saluda Medical Pty Ltd Company Overview | 33 | 1 |
| 5.11.1 Saluda Medical Pty Ltd Pipeline Products &Ongoing Clinical Trials Overview | 33 | 1 |
| 5.12 St. Jude Medical, Inc. Company Overview | 34 | 1 |
| 5.12.1 St. Jude Medical, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 34 | 8 |
| 5.13 University of Illinois at Chicago Company Overview | 42 | 1 |
| 5.13.1 University of Illinois at Chicago Pipeline Products &Ongoing Clinical Trials Overview | 42 | 1 |
| 6 Spinal Cord Stimulators- Recent Developments | 43 | 49 |
| 6.1 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results | 43 | 1 |
| 6.2 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer | 44 | 1 |
| 6.3 Oct 04, 2016: St. Jude Medical Announces FDA Approval of BurstDR Stimulation, a New Superior Spinal Cord Stimulation Option for Patients Suffering from Chronic Pain | 45 | 1 |
| 6.4 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services | 46 | 1 |
| 6.5 Sep 13, 2016: PathMaker Neurosystems Announces the Addition of Institute Professor Emilio Bizzi of MIT to its Scientific Advisory Board | 47 | 1 |
| 6.6 Sep 06, 2016: Publication of Two-Year SENZA-RCT Results in Neurosurgery Demonstrates Sustained Superiority of HF10 Therapy over Traditional Spinal Cord Stimulation for Chronic Pain | 47 | 1 |
| 6.7 Aug 29, 2016: Stimwave s Drug-Free Wireless Pain Relief Neurostimulator Changing the Lives of People Suffering From Chronic Pain | 48 | 1 |
| 6.8 Aug 25, 2016: Medtronic Reports First Quarter Financial Results | 49 | 3 |
| 6.9 Aug 23, 2016: Novel Technology for Veterans with Spinal Cord Injury or ALS to be presented at this year's Paralyzed Veterans of America Summit in Orlando: NeuRx Diaphragm Pacing System Shows Benefit In SCI and ALS Patients | 52 | 1 |
| 6.10 Aug 10, 2016: Nuvectra Reports Second Quarter 2016 Financial Results | 52 | 1 |
| 6.11 Aug 09, 2016: Synapse Biomedical Awarded GSA Schedule for NeuRx Diaphragm Pacing System product line; device will benefit veterans with spinal cord injury (SCI) and ALS | 53 | 1 |
| 6.12 Aug 08, 2016: Nuvectra Announces Formation Of Medical Advisory Board | 54 | 1 |
| 6.13 Aug 08, 2016: Nevro Reports Second Quarter 2016 Financial Results | 54 | 1 |
| 6.14 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 | 55 | 2 |
| 6.15 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results | 57 | 1 |
| 6.16 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors | 58 | 1 |
| 6.17 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic | 59 | 1 |
| 6.18 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation | 59 | 1 |
| 6.19 Jun 06, 2016: Nevro Completes Public Offering of 1.75% Notes Due 2021 for USD172.5 Million | 59 | 1 |
| 6.20 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day | 60 | 1 |
| 6.21 Jun 02, 2016: PathMaker Neurosystems Announces Key Patent Issuance by US Patent and Trademark Office for Fundamental Technology Covering MyoRegulator | 61 | 1 |
| 6.22 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results | 61 | 3 |
| 6.23 May 25, 2016: Hazard alert: Medtronic RestoreSensor implantable neurostimulators | 64 | 1 |
| 6.24 May 24, 2016: InCube Labs Enters into Agreement with University of Pittsburgh | 64 | 1 |
| 6.25 May 19, 2016: Boston Scientific Receives U.S. FDA Approval for Precision Montage MRI Spinal Cord Stimulator System | 64 | 1 |
| 6.26 May 11, 2016: Nuvectra Reports First Quarter 2016 Financial Results | 65 | 1 |
| 6.27 May 09, 2016: Nevro Reports First Quarter 2016 Financial Results | 66 | 1 |
| 6.28 Apr 27, 2016: Abbott Labs to Acquire St. Jude Medical for up to USD25 Billion | 67 | 1 |
| 6.29 Apr 27, 2016: Boston Scientific Announces Results For First Quarter 2016 | 67 | 2 |
| 6.30 Apr 26, 2016: Long-Term Follow Up Study Reports An Overwhelming Majority Of Patients Pleased With Diaphragm Pacing | 69 | 1 |
| 6.31 Apr 20, 2016: St. Jude Medical Reports First Quarter 2016 Results | 69 | 2 |
| 6.32 Apr 19, 2016: G-Therapeutics Raises USD29.4 Million in Series A Financing | 71 | 1 |
| 6.33 Apr 11, 2016: St. Jude Medical Announces US Launch and First Commercial Implants of DRG Stimulation Therapy | 71 | 1 |
| 6.34 Apr 05, 2016: PathMaker Neurosystems and Feinstein Institute Announce Initiation of First Clinical Trial of MyoRegulator to Treat Muscle Contraction | 72 | 1 |
| 6.35 Apr 05, 2016: St. Jude Medical Announces MHLW Approvals of the Proclaim Elite MRI, a Patient-Centric and Recharge-Free Chronic Pain Treatment Option and New SCS Trial System - The Industry's First SCS Systems to Incorporate Apple Digital Devices ... | 73 | 2 |
| 6.36 Mar 14, 2016: Nuvectra Begins Trading on NASDAQ | 75 | 1 |
| 6.37 Mar 03, 2016: Medtronic the First to Offer Complete Portfolio of Full-Body MR Conditional Neurostimulation Systems for Chronic Pain | 75 | 1 |
| 6.38 Feb 25, 2016: Boston Scientific Announces Changes to Board of Directors | 76 | 1 |
| 6.39 Feb 17, 2016: St. Jude Medical Announces FDA Approval Of A New Treatment Therapy For Patients Suffering From Chronic Intractable Pain | 77 | 1 |
| 6.40 Feb 04, 2016: Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2015 | 78 | 1 |
| 6.41 Feb 02, 2016: Mostyn Law wins court order barring Boston Scientific from destroying evidence | 79 | 1 |
| 6.42 Jan 27, 2016: St. Jude Medical Reports Fourth Quarter and Full-Year 2015 Results | 79 | 3 |
| 6.43 Jan 13, 2016: St. Jude Medical Announces Preliminary Fourth Quarter 2015 Financial Results | 82 | 1 |
| 6.44 Dec 11, 2015: LUMINA Data Demonstrate 70 Percent Greater Low Back Pain Relief with Boston Scientific Precision Spectra Spinal Cord Stimulator System | 83 | 1 |
| 6.45 Dec 11, 2015: Long Term Data Confirms the St. Jude Medical Axium System Delivers Sustained and Superior Pain Relief for Patients with Chronic Lower Limb Pain | 84 | 1 |
| 6.46 Dec 11, 2015: New Data Demonstrates Burst Stimulation from St. Jude Medical Provides Superior Pain Relief over Traditional Tonic Spinal Cord Stimulation for the Treatment of Chronic Pain | 85 | 1 |
| 6.47 Dec 10, 2015: Stimwave Receives CE Mark Approval for World s First Wireless Injectable, Eight-Electrode High Frequency Programmable Neuromodulation System | 86 | 1 |
| 6.48 Dec 10, 2015: CMS Approves Transitional Pass-Through Payment for Outpatient Use of Nevro's Senza Spinal Cord Stimulation System | 87 | 1 |
| 6.49 Dec 09, 2015: Stimwave Receives FDA Clearance and Launches Commercialization for World s Smallest Fully-Programmable, Eight-Electrode Wireless Pain Relief SCS System | 87 | 1 |
| 6.50 Nov 30, 2015: St. Jude Medical Introduces Proclaim Elite SCS System In Europe | 88 | 1 |
| 6.51 Nov 30, 2015: Greatbatch Receives FDA Approval of Algovita Spinal Cord Stimulation System | 88 | 1 |
| 6.52 Nov 20, 2015: Northwest Ambulatory Surgery Center Conducts First Commercial Implantation Of The Senza Spinal Cord Stimulator (SCS) In Portland, Oregon | 89 | 1 |
| 6.53 Nov 19, 2015: St. Jude Medical Gets FDA Approval For Proclaim Elite SCS System | 89 | 1 |
| 6.54 Oct 29, 2015: PathMaker Neurosystems Receives Expedited Access Pathway Designation from FDA for MyoRegulator | 90 | 1 |
| 6.55 Oct 28, 2015: Boston Scientific Announces Results For Third Quarter 2015 | 90 | 2 |
| 7 Appendix | 92 | 4 |
| 7.1 Methodology | 92 | 2 |
| 7.2 About GlobalData | 94 | 1 |
| 7.3 Contact Us | 94 | 1 |
| 7.4 Disclaimer | 95 | 1 |
